Consumers in Ireland are being warned not to consume specific batches of Rosabella Moringa 100% Pure capsules due to potential contamination with Salmonella. The recall, issued on Monday, February 23, 2026, affects products sold across the country and originates from a manufacturing issue in the United States. This recall highlights the importance of food safety standards and the potential risks associated with herbal supplements.
The Food Safety Authority of Ireland (FSAI) announced the recall of the affected batches, packaged in white plastic bottles. According to the FSAI, Ambrosia Brands, LLC, the manufacturer, initiated the recall due to the possible presence of the bacteria. Salmonella infection can cause serious illness, particularly in vulnerable populations like the elderly, infants and those with compromised immune systems. The recall underscores the need for consumers to be vigilant about checking product details and adhering to safety alerts.
Understanding the Recall Details
The recalled Rosabella Moringa capsules are identified by a batch code printed on the bottom of the bottle, which is the middle seven digits of the code appearing above the expiry date. The affected batches have best-before dates ranging from March 2027 to November 2027. A comprehensive list of the implicated batch codes and their corresponding best-before dates is available from the FSAI website. Consumers are advised to carefully examine their purchased products and discard any matching the specified criteria.
Moringa is a plant-based supplement gaining popularity for its purported health benefits, including supporting energy levels, boosting the immune system, and providing antioxidants. However, as with any supplement, quality control and safety are paramount. The current recall serves as a reminder that even natural products are not immune to contamination risks.
Symptoms of Salmonella Infection
The FSAI explains that individuals infected with Salmonella typically experience symptoms between 12 and 36 hours after infection, though this timeframe can vary from six to 72 hours. The most common symptom is diarrhoea, which can sometimes be bloody. Other potential symptoms include fever, headache, and abdominal cramps. Although the illness usually lasts between four and seven days, severe cases can require hospitalization, particularly for those with underlying health conditions.
The potential severity of Salmonella infection emphasizes the importance of taking the recall seriously. Consumers experiencing any of these symptoms after consuming the recalled product should seek medical attention.
What Retailers and Distributors are Doing
Wholesalers and distributors have been instructed to immediately contact their customers who may have received the affected batches and to implement a point-of-sale recall notice for consumers. Retailers are required to remove the implicated products from shelves and prominently display recall notices to inform customers. This coordinated effort aims to minimize consumer exposure to the potentially contaminated capsules.
The FSAI is actively monitoring the recall process and working with relevant stakeholders to ensure its effectiveness. Consumers are urged to cooperate with retailers and distributors by checking their purchases and adhering to the recall instructions.
A Broader Concern: Moringa and Drug-Resistant Salmonella
This recall comes amid growing concerns about the safety of moringa products and the emergence of extensively drug-resistant Salmonella strains. A separate outbreak investigation, also underway in February 2026, is focusing on moringa powder and its link to infections resistant to multiple antibiotics, according to reporting from Google News. This investigation, led by the FDA, suggests a potential systemic issue within the moringa supply chain.
While the current recall specifically concerns Rosabella Moringa capsules, the broader investigation raises questions about the overall safety and regulation of moringa products. Consumers should remain informed about ongoing developments and exercise caution when purchasing and consuming these supplements.
The FSAI will continue to provide updates on the recall as more information becomes available. Consumers with questions or concerns are encouraged to contact the FSAI directly or consult their healthcare provider. The next update from the FSAI regarding the recall is expected within the next week, as they assess the effectiveness of the removal of affected products from the market.
This situation serves as a crucial reminder of the importance of staying informed about product recalls and prioritizing food safety. Please share this information with friends and family to ensure everyone is aware of the potential risks.
